Estimating the Benefits of the Comprehensive Disease-modifying Pharmacological Treatment in Patients with Heart Failure. (PubMed, Card Fail Rev) - Sep 16, 2026 - "The numbers needed to treat per year for the primary outcome, cardiovascular death and first heart failure hospitalisation were 10, 23 and 15, respectively. Our findings support the potential benefit of comprehensive therapy, with the incremental role of vericiguat likely greatest in higher-risk patients or those with recent worsening heart failure."
Journal • Review • Cardiovascular • Congestive Heart Failure • Heart Failure
|
|
Ainara Lozano-Bahamonde; Alberto Esteban-Fernández; Alejandro I Pérez-Cabeza; Carles Ràfols; Carlos Escobar; Ines Gomez-Otero; Jesús Saldaña-García; Jose Maria Fernandez-Rodriguez; José Pérez-Silvestre; Pedro Caravaca-Perez
|